Virginia Hemp Retailers Sue State Over New THC Limits

Emergency Rules Target Delta-8, THCA, and Intoxicating Hemp Products

The Virginia Department of Agriculture and Consumer Services published emergency regulations on August 1, 2026, imposing a 0.3% total THC limit per package and prohibiting marketing language that suggests intoxication. The rules apply to all hemp-derived cannabinoids sold in Virginia, including delta-8 THC, delta-10 THC, THC-O, and THCA flower. Products exceeding the threshold or bearing intoxication claims must be removed from shelves by September 15, 2026.

The regulations cite public-health concerns. They align Virginia's hemp program with federal definitions under the 2018 Farm Bill, according to the department's rulemaking notice. VDACS didn't respond to a request for comment by press time.

The lawsuit names VDACS Commissioner Michael Menefee as defendant and seeks declaratory and injunctive relief. Plaintiffs include the Virginia Hemp Trade Association, a nonprofit representing approximately 340 retail locations statewide, alongside three individual retailers: Green Leaf Wellness in Norfolk, Commonwealth Hemp Co. in Charlottesville, and Blue Ridge Botanicals in Roanoke.

Retailers Argue Rules Exceed Statutory Grant of Authority

The complaint alleges VDACS exceeded its rulemaking authority under Virginia Code § 3.2-4112, which authorizes the department to regulate hemp cultivation and processing but doesn't explicitly grant authority to cap cannabinoid concentrations in finished consumer products. Plaintiffs argue the statute's silence on retail product standards means the General Assembly reserved that power for itself.

The filing cites a 2025 Virginia Attorney General opinion concluding that VDACS lacks authority to regulate intoxicating hemp products absent express legislative direction. That opinion, issued in March 2025, responded to a delegate inquiry and has no binding effect but carries persuasive weight in statutory-construction disputes.

Plaintiffs also challenge the emergency-rulemaking process. Virginia's Administrative Process Act requires agencies invoking emergency authority to demonstrate an immediate threat to public health or safety. VDACS provided no evidence of acute harm, the complaint argues, noting that intoxicating hemp products have been sold in Virginia since 2019 without documented overdose deaths or hospitalizations attributable to regulated hemp-derived cannabinoids.

Economic Impact: 340 Retailers, 1,200 Jobs at Stake

The Virginia Hemp Trade Association estimates the new rules will force 60% of its member retailers to close within 90 days, eliminating approximately 1,200 full-time jobs and $180 million in annual revenue. The association's economic-impact analysis, attached as an exhibit to the complaint, projects a 72% decline in hemp-product sales if the regulations take effect.

Green Leaf Wellness owner Marcus Thompson said in a declaration filed with the suit that delta-8 and THCA products account for 85% of his store's revenue. Thompson opened his Norfolk location in 2021. He employs seven people. Insolvency by November 2026 is likely if the regulations stand, he projects.

Commonwealth Hemp Co. in Charlottesville reported similar exposure. Owner Rebecca Lin stated that her inventory includes approximately $40,000 in delta-8 gummies and THCA flower that would become unsaleable under the 0.3% cap. She lacks the capital to absorb that loss and would likely close her two locations, which employ 11 people combined.

THCA Flower Retailers Face Steepest Losses

THCA flower—raw cannabis flower sold as hemp because it contains less than 0.3% delta-9 THC by dry weight—represents the fastest-growing segment of Virginia's hemp market and faces near-total elimination under the new rules. THCA is non-intoxicating in its raw form but converts to delta-9 THC when heated, a process called decarboxylation. Retailers sell THCA flower for smoking or vaporization. The product competes directly with illicit-market cannabis.

The 0.3% total-THC cap treats THCA as equivalent to delta-9 THC, effectively banning THCA flower. Industry data compiled by the Hemp Trade Association shows THCA flower sales grew 340% in Virginia between January 2025 and July 2026, reaching $22 million in monthly revenue statewide by mid-2026.

Blue Ridge Botanicals in Roanoke specializes in THCA flower and reports that 94% of its revenue derives from that product category. Owner Daniel Ortiz stated in his declaration that he invested $120,000 in build-out and inventory in 2025 based on the regulatory status quo. He can't pivot to compliant products without shuttering the business.

Federal Preemption Argument Hinges on Farm Bill Language

Plaintiffs assert federal preemption, arguing that the 2018 Farm Bill's definition of hemp—cannabis containing no more than 0.3% delta-9 THC by dry weight—occupies the field and bars states from imposing stricter cannabinoid limits. The complaint cites the Farm Bill's explicit authorization for states to regulate hemp production but notes the statute doesn't grant states authority to redefine hemp or impose additional cannabinoid restrictions on federally compliant products.

This argument faces headwinds. Courts have generally held that the Farm Bill's preemption clause applies only to state laws that prohibit the transportation or sale of hemp in interstate commerce, not to state regulations that impose additional consumer-protection standards. A 2024 ruling from the U.S. District Court for the Western District of North Carolina upheld that state's ban on delta-8 products, finding no conflict with federal law.

Virginia's lawsuit distinguishes the North Carolina case on procedural grounds, arguing that VDACS invoked emergency rulemaking without the evidentiary showing required under Virginia's Administrative Process Act. Whether that distinction carries weight depends on how the Richmond Circuit Court interprets the scope of VDACS's statutory authority, not on federal preemption doctrine.

Timeline: Hearing Set for September 5, Compliance Deadline September 15

The court scheduled a preliminary-injunction hearing for September 5, 2026, ten days before the compliance deadline. Plaintiffs seek a temporary restraining order halting enforcement pending resolution of the case. VDACS has until August 30 to file a response.

If the court denies injunctive relief, retailers must remove non-compliant products by September 15 or face civil penalties of up to $1,000 per violation per day under Virginia Code § 3.2-4121. VDACS has discretion to pursue administrative sanctions, including license suspension or revocation, for retailers who continue selling prohibited products.

The General Assembly reconvenes in January 2027. Several delegates have signaled interest in clarifying VDACS's authority through legislation, but no bills have been pre-filed. For full background on this story, see the CannIntel topic hub on Virginia hemp THC restrictions.

The outcome hinges on statutory construction. If the court finds VDACS exceeded its grant of authority, the regulations fall regardless of their policy merit. If the court defers to the agency's interpretation, the hemp retailers' best path forward is legislative, not judicial.